About inveox GmbH
Pathology 4.0® – the lab of the future Founded in Munich in 2017, inveox GmbH develops systems for digitalization and automation of sample intake in histopathology as well as for networking pathology labs and treating physicians. Time-consuming, highly manual laboratory processes in pathology are expensive, error-prone, and the most common cause of misdiagnosis. inveox has developed an innovative solution for capturing, intake, and preparation of histopathological laboratory samples. The system consists of an intelligent sample container, an automated sample intake machine, and an online platform for data transfer between treating physician and lab. With digitalized, fully automated, and networked histopathology, inveox aims to improve the safety and reliability of cancer diagnoses, while increasing the efficiency and profitability of labs and unlocking the potential for personalized diagnostics based on big data and artificial intelligence. Since its founding, inveox has won numerous awards and was finalist for the Digital Startup of the Year 2020 award from the Federal Ministry for Economics and Energy, the EIT Health Award 2019, the German Innovation Prize 2019, and the World Health Summit Award 2018. The young company made it onto the Forbes list of “Most Promising Startups 2018”, has been a member of the World Economic Forum since 2019, and has already been featured in articles and reports in various renowned print media such as Handelsblatt and Wirtschaftswoche. With offices in Krakow (Poland) and Houston (Texas, USA), the startup now has over 100 team members.
Discover relevant articles, startups, and events from the ecosystem
Online: Holding structures: Implementation and benefits for startups
